GSK Aktie
18,85
EUR
+0,24
EUR
+1,26
%
16,31
GBP
+0,06
GBP
+0,37
%
Werbung
GSK Aktie Analyse
| 07.02.13 | GSK halten | Credit Suisse Group | |
| 07.02.13 | GSK verkaufen | Exane-BNP Paribas SA | |
| 07.02.13 | GSK kaufen | National-Bank AG | |
| 05.02.13 | GSK halten | Nomura | |
| 22.01.13 | GSK | Exane-BNP Paribas SA | |
| 12.12.12 | GSK neutral | Credit Suisse Group | |
| 12.12.12 | GSK hold | Deutsche Bank AG | |
| 11.12.12 | GSK halten | Norddeutsche Landesbank (Nord/LB) | |
|
Werbung
|
|||
| 04.12.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 04.12.12 | GSK underperform | Exane-BNP Paribas SA | |
| 28.11.12 | GSK kaufen | National-Bank AG | |
| 26.11.12 | GSK underperform | Exane-BNP Paribas SA | |
| 19.11.12 | GSK hold | Deutsche Bank AG | |
| 14.11.12 | GSK halten | Hamburger Sparkasse AG (Haspa) | |
| 05.11.12 | GSK buy | Citigroup Corp. | |
| 02.11.12 | GSK neutral | UBS AG | |
| 02.11.12 | GSK halten | Independent Research GmbH | |
| 02.11.12 | GSK underperform | Exane-BNP Paribas SA | |
| 02.11.12 | GSK neutral | Credit Suisse Group | |
| 01.11.12 | GSK neutral | UBS AG | |
| 01.11.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 25.10.12 | GSK underperform | Exane-BNP Paribas SA | |
| 23.10.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 18.10.12 | GSK neutral | UBS AG | |
| 12.10.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 11.10.12 | GSK hold | Deutsche Bank AG | |
| 05.10.12 | GSK neutral | Credit Suisse Group | |
| 14.09.12 | GSK buy | Citigroup Corp. | |
| 11.09.12 | GSK underperform | Cheuvreux SA | |
| 10.09.12 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 06.09.12 | GSK neutral | UBS AG | |
| 05.09.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 04.09.12 | GSK outperform | Exane-BNP Paribas SA | |
| 29.08.12 | GSK neutral | UBS AG | |
| 28.08.12 | GSK neutral | UBS AG | |
| 28.08.12 | GSK buy | Citigroup Corp. | |
| 28.08.12 | GSK hold | Deutsche Bank AG | |
| 28.08.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.08.12 | GSK hold | Deutsche Bank AG | |
| 24.08.12 | GSK outperform | Exane-BNP Paribas SA | |
| 23.08.12 | GSK buy | Citigroup Corp. | |
| 20.08.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 16.08.12 | GSK neutral | Goldman Sachs Group Inc. | |
| 15.08.12 | GSK neutral | Nomura | |
| 03.08.12 | GSK halten | Independent Research GmbH | |
| 31.07.12 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 27.07.12 | GSK buy | UBS AG | |
| 26.07.12 | GSK buy | UBS AG | |
| 26.07.12 | GSK neutral | Sarasin Research | |
| 26.07.12 | GSK equal-weight | Morgan Stanley | |
Werbung
Werbung